最新报道:180 Life Sciences Corp. shares dropped 14.02% amid market volatility as investors shifted focus to Ethereum and other crypto assets. The biotech firm's stock decline reflects broader sector turbulence, with traders moving capital into digital assets like Ethereum, which has seen increased institutional interest. Analysts note the sell-off highlights growing competition between traditional equities and cryptocurrencies for investor attention during periods of economic uncertainty.